RedHill Biopharma Ltd. ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced its plan to submit a UK Marketing Authorisation Application (MAA) for Talicia for treatment ...
BioVaxys Technology Corp. (FRA: 5LB) ("BioVaxys" or "Company") is providing this bi-weekly update on the status of the management cease trade order granted on March 3, 2025 (the "MCTO"), by its ...
RedHill plans to submit UK MAA1 for Talicia for H. pylori infection, using MHRA's2 new fast-track approval process, referencing FDA approval, with potential UK approval ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback
